Talc Ovarian Cancer Debunked Science Based Medicine – Are You Eligible To File A Talc Lawsuit?

You May be Entitled to Significant Compensation Talc ovarian cancer debunked science based medicine. Johnson & Johnson powders were proven to contain asbestos (a cancer causing agent) and the company failed to notify users of the cancer risk. $2 BILLION has already been awarded to claims. Free To File! No Fees Unless A Settlement Is Awarded!

J&J’s proposed talc settlement will pay $440 million US state AGs. Talc Ovarian Cancer Debunked Science Based Medicine .

Johnson & Johnson (JNJ.N) has put aside $400 million to settle U.S. state consumer protection actions as part of a broad $8.9 billion plan to settle allegations that it’s Baby Powder and other talc products cause cancer. Talc ovarian cancer debunked science based medicine.

J&J affiliate LTL Management filed a bankruptcy plan in New Jersey late on Monday that describes how the company intends to pay different types of cancer sufferers in an arrangement for bankruptcy. Talc ovarian cancer debunked science based medicine. J&J has said that its Talc products are safe, and will not cause cancer. It is attempting for another time to settle more than 38,000 lawsuits in bankruptcy, as well as prevent new lawsuits from coming forward in the near future.
LTL’s bankruptcy plans would deposit $400 million to a separate trust for claims brought in state courts by attorneys general alleging that J&J had violated states’ unfair practices as well as consumer protection laws by misinforming consumers about the security of its talc-based products.

A number of states had already initiated consumer protection actions against J&J before LTL’s first bankruptcy filing stopped these investigations from taking place in 2021. Talc ovarian cancer debunked science based medicine. New Mexico and Mississippi had already initiated actions with Johnson & Johnson before then, and the states of Arizona, Maryland, North Carolina, Texas and Washington had issued civil investigative requests or subpoenas according to court papers.

 

 

New Mexico and Mississippi have filed a petition to end LTL’s bankruptcy in a joint move with cancer victims as well as those affected by cancer and the U.S. Justice Department’s bankruptcy watchdog. They have argued that a profitable firm like J&J can’t benefit from bankruptcy protections intended for the struggling debtors.
LTL’s first attempt at resolving the bankruptcy lawsuits was thrown out after similar arguments. A U.S. appellate court ruled the LTL did not have “financial trouble” and therefore not eligible for bankruptcy protection. Talc ovarian cancer debunked science based medicine. LTL made a new bankruptcy application less than two hours after that dismissal, arguing that its second attempt was different in that it was able to borrow less and had more support for an agreement.

New Mexico and Mississippi said in their motion to dismiss LTL’s renewed bankruptcy violates state law enforcement powers by attempting unilaterally to cap the liability of the company for state consumer protection laws.

 

Talc Ovarian Cancer Debunked Science Based Medicine

LTL’s recent filings also provided additional details about how the company would assess and pay claims for cancer should the bankruptcy plan be approved.

The maximum amount under the settlement would be $500,000 for patients diagnosed with mesothelioma terminal prior to the age of 45, and $260,000 for those who have been diagnosed with terminal ovarian cancer before age 45.

From there, the proposed settlement offers discounts based on the severity and type of the cancer, the person’s age, the history of the use of talc, and other aspects. Talc ovarian cancer debunked science based medicine. For example an individual who was using the talc product on a regular basis, had a family history of ovarian cancer and was diagnosed with an ovarian cancer stage II at the age of 55 may be eligible for a $21,125 payout under the settlement plan.

Judge orders J&J and talc oppositionists to discuss settlement negotiations.

Following another hearing in Johnson and Johnson’s efforts to employ a Texas Two Step bankruptcy strategy for talc litigation and federal bankruptcy judge Michael Kaplan has ordered the company and those opposing the strategy to engage in settlement talks, Bloomberg reports.

With its second bankruptcy attempt for LTL management, a subsidiary founded by J&J to hold the claims–the company made a settlement offer of $8.9 billion. Talc ovarian cancer debunked science based medicine. While a firm representing plaintiffs agree with the deal, another group is against the settlement.

The previous week, the opposition group, called the Official Committee of Talc Claimants in the bankruptcy court, demanded to dismiss this case by arguing that LTL is not considered to be to be in financial trouble.

“The filing is an unjust and legally flawed attempt by a small number of law firms to stop claimants from voting on the resolution, which that the overwhelming majority of claimants are in favor of,” J&J’s litigation chief Erik Haas, said in an announcement. Talc ovarian cancer debunked science based medicine. “The law firms behind the filing are pursuing financial interests which conflict with, contradict and are in opposition to the interests which their clientele. We will be submitting an answer in the appeals court.”

Talc ovarian cancer debunked science based medicine. Clay Thompson, a lawyer for MRHFM that boasts more than mesothelioma clients who have filed lawsuits against J&J claimed that J&J’s second bankruptcy attempt failed.

“J&J sends out press releases about how wonderful its plans are, but is demanding that plan details–including what each sick person will receive–be kept secret,” Thompson said in the statement. “What do they have to keep secret?”

 

Blog Talc JPML

 

Kaplan has instructed both sides to develop a new reorganization plan, under the oversight from two mediators.

On February 20, 2022 Kaplan stated that J&J’s recourse to Chapter 11 to hasten a settlement that would free J&J from the thousands of lawsuits over its talcum products.

In the month of January, an appeals court of the federal government overturned the verdict, ruling that the company could not be considered in “financial trouble.”

When J&J’s attempt to make an appeal before the U.S. Supreme Court was turned down at the end of April J&J applied for its first bankruptcy two hours later. In response, Kaplan froze the lawsuits for 60 days in order to determine whether or not to accept the second bankruptcy.

J&J’s unstoppable profit machine sputters after $6.9B settlement charge for talc.

Through Two Chapter 11 attempts, J&J has gotten 19 months of which the cases were on hold. Talc ovarian cancer debunked science based medicine. The company is requesting that claimants take a vote to accept their settlement. J&J needs 75% approval for the deal to go through.

In addition to the gang of talc lawyers who criticised the company’s bankruptcy play in the U.S. Trustee, the U.S. Trustee, a branch belonging to the U.S. Department of Justice has also filed an application to dismiss the second bankruptcy case of LTL.

In a filing this week, U.S. trustee Andrew R. Vara wrote that the doors of bankruptcy courts are “open to honest, but naive debtors.” Those doors “are not available to anyone who do not have a legitimate bankruptcy goal or who seek to take advantage of the bankruptcy process to delay or hinder their creditors.” Vara continued.

To its credit, J&J maintains there is no proof conclusive that their talc products, including its popular baby powder can cause cancer. J&J has adopted the products of the market–first on North America in 2020–and the rest of the world this year.

J&J wants to avoid the cost of going to court. It has won the majority of cases decided at trial, but certain losses have been extremely punishing.
A well-known trial in Missouri resulted in a $4.7 billion verdict against the drug company and was later lowered to $2.1 billion following appeals.

Johnson & Johnson faces high-stakes hearing over ‘Texas Two Step’ talc strategy: report
Overall, J&J has lost nine trial cases in talc which are in appeal or resolved. Out of 41 trials 32 of them ended in winning for J&J or a mistrial, or plaintiff verdict that was annulled after appeal. Talc ovarian cancer debunked science based medicine. In addition, J&J in 2020 sought to settle more than 1000 cases for $110 million. Bloomberg published at the time.

 

Talcum Baby Powder Ovarian Cancer Lawsuit – Talc Ovarian Cancer Debunked Science Based Medicine

Our lawyers are handling baby powder cases in all 50 states. The talcum powder lawsuits on behalf of Johnson & Johnson have been in the process for several years. Talc ovarian cancer debunked science based medicine. The lawsuits contend that the prolonged use of talcum powder (or “talc”), the active ingredient in products such as Baby Powder along with Shower to Shower and Shower to Shower, could cause ovarian cancer in some women.

This article provides an J&J talc power litigation update and discusses how the upcoming bankruptcy ruling will affect the final settlement amounts of these Ovarian Cancer lawsuits.

Did the deadline expire for you to start a lawsuit against talcum powder? Many who assume the statute of limitations has run out to file a lawsuit against Johnson & Johnson are wrong. Call us at 800-553-882 or get a no-cost, quick review of your case online.

 

Johnson and Johnson Talcum Powder Lawsuit Update 2023 – Talc Ovarian Cancer Debunked Science Based Medicine

June 2 2023 Update: In the asbestos talc case which took place in California yesterday, technical glitches interrupted the opening speech of defense lawyers. Talc ovarian cancer debunked science based medicine. Jurors watching from home on Zoom however, heard Johnson & Johnson’s lawyer expressing doubts about the 70s research affirming the presence of asbestos in their product, but the proceedings abruptly ended.

Meanwhile, the plaintiff could present its first expert witness Arthur Langer. Langer said that the presence of other minerals in the talc mineral is a given. He said that his team informed J&J in 1971 about the presence of chrysotile asbestos in the talc of the company, but with less than 0.1 percent. He also uncovered more asbestos in 1976.

June 1st, 2023 Update: Talc ovarian cancer debunked science based medicine. First trial after J&J decided to spin off its Talc segment and file for bankruptcy is an important point in the ongoing talc litigation story. The trial began on Tuesday in the tragic case of a young 24-year-old plaintiff who was diagnosed with a rare and aggressive type of mesothelioma in the past year, a diagnosis lawyers on both sides agree is a tragic loss.

The opening statements exposed the sharp differences in the two sides’ narrative. The plaintiff’s attorney took aim on Johnson & Johnson, alleging the use of misleading strategies in its research practices as well as throughout the litigation process. As per the lawyer the company tried to manipulate the definition of asbestos, despite internal documents from the year 1978 and 1994 indicating that fibers discovered in the tissue of the plaintiff are included.

Johnson &J’s highly uncertain $8.9 billion settlement offer hangs in the balance with the progression of this trial. Despite the unique nature of this mesothelioma-related case and its distinct issues compared to other lawsuits involving talcum powder ruling in favor of the plaintiff could be an enormous setback for J&J’s expectations of widespread acceptance of the settlement they have proposed among plaintiffs.

May 31, 2023: Update from Johnson and Johnson’s bankrupted talc unit has vigorously defended its second Chapter 11 filing in the face of challenges from injured talc claimants. In a written objection to the New Jersey bankruptcy court, the subsidiary argued that the situation differed fundamentally from the prior filing. It highlighted the extraordinary commitment to $8.9 billion to J&J which is the largest settlement ever made in a mass tort bankruptcy case. Talc ovarian cancer debunked science based medicine. The issue is not discussed: whether the size of the settlement implies that it is an equitable settlement. J&J also claimed that it received support from numerous plaintiffs’ law companies representing over the 60,000 plaintiffs. It is difficult to confirm however it is likely to be incorrect.

May 24 2023 Update: As of Johnson &J Johnson’s bankruptcy filing, the first trial concerning its cosmetic talc products allegedly comprised of asbestos is set to start jury selection on Monday in California with Alameda County Superior Court, which is a well-known place for plaintiffs. The plaintiff claims his mesothelioma was caused by asbestos exposure through J&J’s products, an allegation J&J denies. The trial also involves six retailers accused of selling talc-containing products.

May 22nd, 2023 Update: Lawyers in the 2nd J&J Talc bankruptcy are currently battling over who should be chosen to fill the position of the future claims representative, a role that is critically essential in resolving the claim for talc. Talc ovarian cancer debunked science based medicine. Randi Ellis, a lawyer who regularly appears in MDLs throughout the United States, was appointed as the claims representative during the first bankruptcy. J&J’s defense group wants Ellis to be named to the position and again, but attorneys for the plaintiffs in talc are arguing because Ellis has an interest conflict which would prohibit her from being appointed to that post for the second time. The conflict stems from the issue that Ellis was involved in drafting the hotly contested second bankruptcy, raising doubts about her capacity to be neutral. It’s true that this bankruptcy is likely to get dismissed anyway.

May 17, 2023 Update The fake company J&J put together to settle the talc litigation bankruptcy has informed a New Jersey bankruptcy court that they have designated $400 million to pay the claims made by states accusing J&J of misleading marketing for its talc products. Talc ovarian cancer debunked science based medicine. That’s an $8.5 billion settlement for cancer patients. It’s difficult to imagine an eventuality where J&J can get these baby powder settlements through in these figures. While J&J’s proposed $8.5 billion offer might seem like a large sum initially, it will not look good when you look at the numbers. This settlement offer based on our rough calculations would not offer victims anything more than a median settlement of $100,000 per instance. That’s not enough.

May 15 2023 Update J&J may be in the middle of a lawsuit from an advocacy group representing cancer patients. Talc ovarian cancer debunked science based medicine. The group argues that J&J intentionally withdrew a $61.5 billion fund-raising agreement that it had with its company subsidiary LTL Management LLC, to simulate financial distress and validate the unit’s Chapter 11 bankruptcy filing. The group claims that this move is a fraud transfer of the right to compensation for victims. They intend to investigate J&J’s actions following of the decision to dismiss the first bankruptcy case of LTL.

May 10 2023 Update: Next week in it is expected that the U.S. Bankruptcy Court in New Jersey will hear oral arguments on a petition to dismiss the second bankruptcy filing from J&J company LTL Management. However, in the meantime, the bankruptcy has issued an order which requires both sides to take part in a second settlement mediation hoping that it will be possible to reach a global settlement agreement reached.

May 5th 2023 Update: Talc producer Whittaker, Clark & Daniels filed for Chapter 11 bankruptcy due to several lawsuits alleging that its talc products cause cancer due to asbestos exposure. Talc ovarian cancer debunked science based medicine. Over 2,700 people have sued the company and it is spending $1 million a month to defend itself. The company’s recent $29 million settlement at the Supreme Court of South Carolina forced it to apply for bankruptcy protection and argue for equitable distribution of assets among talc claimants instead of being confiscated through the receiver. Other suppliers of talc have declared bankruptcy because of lawsuits.

May 4, 2023 update: U.S. Bankruptcy Judge Michael Kaplan has directed Johnson & Johnson to restart talks with lawyers who rebuffed the proposed $8.9 billion agreement. In Trenton, New Jersey yesterday the parties appeared in court to discuss the next steps to take in the second bankruptcy case and Judge Kaplan has pushed for further settlement talks.

This is the solution to resolve these claims for J&J. A settlement for baby powder can be completed. Talc ovarian cancer debunked science based medicine. However, it will require more money, more billions of dollars – from Johnson & Johnson.

Lawyers are split on whether or not to accept the plan and not every client views this issue the same way their lawyer does. Second bankruptcy cases are destined to go nowhere as Judge Kaplan has scheduled a hearing for June to decide if he will close the case for the third time.

May 3 2023 Update: A group representing cancer patients who have sued Johnson & Johnson (J&J) asked to have J&J’s Third Circuit halt the bankruptcy filed by J&J subsidiary LTL Management, claiming it is an attempt to derail litigation regarding talc-related products. The group representing the claimants submitted a motion on Tuesday, asking that the Third Circuit to consider their case and then send it back before a court of lower jurisdiction, with instructions to discharge the bankruptcy. Talc ovarian cancer debunked science based medicine. They also requested that the halted tort litigation against J&J continue to proceed.
LTL filed for Chapter 11 protection once again following the bankruptcy filing it made earlier was denied in the Third Circuit earlier this year with a $8.9 billion deal. The committee believes that the recent ruling, which allows LTL’s 2nd Chapter 11 to continue, in addition to halting trials against J&J is a reason for urgent Third Circuit review. The US Trustee also requested that be the New Jersey bankruptcy court dismiss the LTL bankruptcy case. J&J’s global vice president of litigation Erik Haas, was quoted by Bloomberg as saying that J&J plans to file a reply to the appeals court declaring the filing a “desperate and legally flawed plan” by a few of law firms who have competing financial interests.
May 1st 2023 Update: One frequently asked question is how plaintiffs and their lawyers be able to turn on $8.9 billion. Of course, it’s a lot of money. However, there are lots of victims. Talc ovarian cancer debunked science based medicine. These are actually a good cases for plaintiffs. We were reminded recently by two talc-related trials that have resulted in huge verdicts for plaintiffs. In February the mesothelioma case involving talcum powder trial in Oregon resulted in a verdict worth $18.1 million. In the same month, a different mesothelioma talc case was brought to trials in South Carolina and resulted in an award of $29 million for the plaintiff. Both cases were defended by Whittaker, Clark & Daniels Inc., one of the most prominent suppliers of talc within the U.S.
April 30, 2023 Update: When J&J first attempted to drag the lawsuit over talcum powder into bankruptcy, it came with an offer to reserve $2 billion for settlements. The amount was absurdly low. None of the talc plaintiffs believed in the proposal. This time, however, J&J has increased the offer to $8.9 in the event that the talc victims will allow a bankruptcy settlement and they also have the backing of a significant segment of the talc plaintiffs as well as their lawyers. Talc ovarian cancer debunked science based medicine. However, 75% of plaintiffs in the talc category, which is needed for approval of the bankruptcy plan is a difficult road with so many lawyers with huge stocks of baby powder-related lawsuits, opposed towards the agreement.

What could solve the impasse? More billions.
April 25, 2023, Update Talc Cancer victims have demanded a judge disqualify the Chapter 11 case filed by LTL Management LLC, a absurdly fabricated Johnson & Johnson subsidiary, insisting that the company is not financially strained. LTL has filed for Chapter 11 to settle tens of thousands of claims that J&J’s baby products caused cancer. Talc ovarian cancer debunked science based medicine. In the end, however, the 3rd Circuit dismissed its first Chapter 11 case in January and said that the company wasn’t eligible for bankruptcy relief since it had not demonstrated financial difficulties.

The claimants contend that LTL’s third Chapter 11 case is an overreach of the bankruptcy system and it’s being pursued in bad faith. J&J asserts that the bankruptcy settlement has “significant backing” from firms representing approximately 60,000 plaintiffs. It’s safe to say that lawyers representing plaintiffs and victims ‘ lawyers are divided on the $8.9 billion settlement offer.

April 21st, 2023 Update: A bankruptcy judge decided in favor of Johnson & Johnson must face new lawsuits alleging that the firm sold a baby powder that contained a chemical that causes cancer. Although the trials for the lawsuits involving talc are delayed for a minimum of 60 days and new lawsuits are able to be filed and lawyers are able to begin preparing their cases. Talc ovarian cancer debunked science based medicine. The judge expressed his doubts about J&J’s absurd attempt to revive its strategy with the second bankruptcy case.

April 13th 2023 Update: The big update is about the $8.9 billion over the course of 25 years offer for settlement. Lawyers representing cancer victims involved in MDL class action MDL Class Action have vowed to fight the settlement with those who claim talc. Why? They believe it’s not enough to pay for 70 000 cancer patients. Talc ovarian cancer debunked science based medicine. The lawyers say that J&J could negotiate a greater settlement or litigate individuals’ claims if the current bankruptcy is declared unconstitutional.

There is a different group of lawyers outside of the top leadership in the class action. These lawyers have amassed many thousands of cases. They want to settle today for what is believed to be less than these victims deserve. Their argument appears to be twofold. The first is that they claim the settlement, which is about an average of $100,000 per plaintiff – is fair.

This is an argument that is difficult to make. The second argument is more force: victims should no longer wait and want their money now.

April 12 2023 Update: People are looking for ways J&J is able to file for bankruptcy again. The answer is complicated and convoluted. Let’s try to simplify it in simple terms.
Johnson & Johnson asserts that bankruptcy is the only option to settle both present and future talc-related lawsuits definitively. In other words, it believes that it will be less expensive should there be a bankruptcy element that creates pressure to negotiate a settlement. Talc ovarian cancer debunked science based medicine. Going back to the 400-year span of American time, the business argues that bankruptcy benefits all parties as it distributes settlements more equally and more efficiently than trial courts where some litigants receive significant award while others do not.

The basic tenet of this 3rd Circuit decision was this is not a case of an enterprise that is profitable, forming a subsidiary to take the legal liability and declare bankruptcy, which is what Congress had in mind when it came to drafting the Bankruptcy Code. However, it also stated the company was financially distress because J&J promises unlimited funding.
Then J&J did not hesitate to take advantage of the unlimited funding part of the deal and didn’t promise that it would provide unlimited funds for cases. J&J claims that its revised financing arrangements with its subsidiary address the concerns of the appellate court, while supplying funds for claim payments. It’s as if giving victims less money would solve the overall issue.

Attorneys representing cancer patients who are against the agreement argue this by arguing that the plaintiff is the legal argument. Talc ovarian cancer debunked science based medicine. They counter with legal absurdity: J&J fraudulently transferred $50 billion of assets away from LTL Management to circumvent the appeals court’s decision. Hyperbole is not exempt by the victims’ lawyers, who call it the largest “fraudulent transfer in United States history.”

Despite the legal jargon, J&J does not really think this bankruptcy will survive. But it’s a way to push for this $8.9 billion settlement, and to keep pressure on plaintiffs.

April 10, 2023, Update Bloomberg is running an intriguing report on a brand new law in New Jersey that is shedding new light on litigation funding in the baby powder suit for class actions. The funders who fund litigation Virage Capital Management and TRGP Capital invested in hundreds of lawsuits that were brought against Johnson & Johnson (J&J) on behalf of talc products. They exchanged for a share of any winnings. J&J is now offering an offer of $8.9 billion to settle all lawsuits.

The funders’ involvement is publicly available due to a New Jersey court rule requiring the release of certain details about outside funding backers. The rules aim to address the growing calls for regulation of the litigation funders. J&J is facing more than 60,000 claims when you combine state and federal child powder-related lawsuits. Third-party funding in mass tort claims has pros and cons. However, there is no doubt that we are witnessing how third-party funding could level the playing field between individual as well as large corporations in the courtroom.

April 4 2023 Update: It is fun to watch the worm turning in this litigation. J&J was hit again this week, when an appeals court in the Third Circuit denied J&J’s request to continue the automatic stay during the time that J&J appeals an appeal to the U.S. Supreme Court. The automatic stay has stopped the cases of talcum powder in a number of years and stopped any new lawsuits from getting filed ever since J&J began the controversial plan to spin the talc liabilities off into a bankrupt entity over one year back. Talc ovarian cancer debunked science based medicine. When the 3rd Circuit ruled that this bankruptcy was not legal some months ago, the stay was lifted. J&J was hoping to have it continue in the meantime of its SCOTUS appeal. The answer was no.
April 1st, 2023 Update Johnson & Johnson announced it will appeal its 3rd Circuit bankruptcy loss to the U.S. Supreme Court last week. The likelihood that the Supreme Court is willing even to hear the appeal? Low.
March 16 2023 Update: With the bankruptcy stay now officially lifted, the very first new cases were filed and incorporated into the class action for talcum powder MDL in over one year. Seven new talc cases were included in the MDL in the last month increasing the number of cases that are pending to 37,522.

February 25, 2023 Update 2023 Update: A Congressmen from Tennessee has now demanded that authorities from the U.S. Government Accountability Office (GAO) start an investigation to determine how much J&J products containing talc have cost the government in the decades.
Recently, in an open letter to the GAO, Rep. Steven Cohen (D-Ten.) claimed that J&J of failing to recognize the dangers of its talc products for years while tax dollars were utilized to treat people injured by exposure to the products. The demand comes just weeks following J&J’s dramatic loss in the 3rd Circuit Court of Appeals.

Talc ovarian cancer debunked science based medicine. J&J should begin to make reasonable settlements for victims in order in putting this behind it. It is a stain on one of the world’s greatest firms.

February 14 2023 Update: During a hearing today in New Jersey, U.S. Bankruptcy Judge Michael Kaplan announced his intention to follow the 3rd U.S. Circuit Court of Appeals ruling to dismiss the bankruptcy case.

 

You May be Entitled to Significant Compensation Talc ovarian cancer debunked science based medicine. Johnson & Johnson powders were proven to contain asbestos (a cancer causing agent) and the company failed to notify users of the cancer risk. $2 BILLION has already been awarded to claims. Free To File! No Fees Unless A Settlement Is Awarded!

 

  • How To Get A Divorce Decree Online And Avoid The Courts – Cheap Online Divorce Lawyers Near Me
  • Can You File For Divorce Online In Mississippi – Cheap Online Divorce Lawyers Near Me
  • Johnson And Johnson Talc Powder Cancer – Are You Eligible To File A Talc Lawsuit?
  • Family Divorce Online Cope Class Las Vegas – Cheap Online Divorce Lawyers Near Me
  • Quick Easy Online Divorce – Cheap Online Divorce Lawyers Near Me
  • Johnson And Johnson Class Action Bedtime – Are You Eligible To File A Talc Lawsuit?
  • Divorce Records Florida Look Up Online Free – Cheap Online Divorce Lawyers Near Me
  • Talc In Makeup Is It Dangerous – Are You Eligible To File A Talc Lawsuit?
  • Divorce In Fl Online – Cheap Online Divorce Lawyers Near Me
  • Is Ponds Talc Safe – Are You Eligible To File A Talc Lawsuit?
  •  

  • Contact
  • Free Do It Yourself Divorce Forms
  • Terms of Use
  • Disclosure
  •  

    >>> Talc Ovarian Cancer Debunked Science Based Medicine

    You May Also Like